Latest news
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Analysts Just Trimmed Their Revenue Forecasts By 19% - simplywall.stsimplywall.st · Mon, 10 Aug 2026 10:46:51 GMTRecursion Pharmaceuticals, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:RXRX) 2026-08-09 - Seeking AlphaSeeking Alpha · Sun, 09 Aug 2026 23:17:37 GMTRecursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144 - MoomooMoomoo · Sat, 08 Aug 2026 00:33:02 GMTRecursion Pharmaceuticals Inc (RXRX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKeyTradingKey · Fri, 07 Aug 2026 15:03:51 GMTRecursion Pharmaceuticals | SCHEDULE 13G: Others - MoomooMoomoo · Fri, 07 Aug 2026 14:49:17 GMTRecursion Pharmaceuticals Inc (RXRX) Stock Analysis & Forecast - TradingKeyTradingKey · Fri, 07 Aug 2026 13:19:07 GMTRecursion Pharmaceuticals (RXRX) Director Blake Borgeson Sells 3 - GuruFocusGuruFocus · Fri, 07 Aug 2026 07:50:49 GMTRecursion Pharmaceuticals (RXRX) director sells 30,000 shares in 10b5-1 plan - Stock TitanStock Titan · Thu, 06 Aug 2026 21:10:07 GMT